Gastroenterologists continue to struggle to maintain a work-life balance.

Published Date: 02 Mar 2023

According to a new report from Medscape, many gastroenterologists have found that happiness levels and work-life balance are not easily restored, despite the impact of COVID-19 in the office.

Read Full News

Latest News

Is the Combination of GLP-1s and Clozapine Safe?

Gastrointestinal hypomotility is the most lethal adverse event linked to clozapine use. GLP-1s slow the gut too. Clinicians are combining the two, with little safety data to guide them.

Health Round: Experimental Blood Test Finds High-risk Colorectal Lesions Before Cancer Develops

We also report on a flavoring chemical in e-cigarettes that damages human embryo cells in lab experiments.

Constipation Relief: Elobixibat Outperforms Prucalopride

Elobixibat offers faster and greater symptomatic relief than prucalopride among patients with functional constipation unresponsive to first-line treatment.

Pancreatic Cysts: Sparing Use of Invasive Tests Seems Safe

Guidelines call for strict limits on invasive tests for pancreatic cyst surveillance, and a new study supports the strategy’s safety.

Patients’ Wait Times for Cancer Surgeries Keep Growing

Wait times for potentially curative cancer surgery, which have been climbing steadily for more than a decade, have risen particularly rapidly at high-volume academic centers.

Taylor Farms Outbreaks Show Limits Of US Ability to Safeguard Produce From Mexico

Two foodborne illness outbreaks linked to Taylor Farms have exposed a weakness at the heart of North America's food system: the United States is increasingly relying on...

Todays Updates

Belgian Algorithm Reshapes Endometrial Cancer Care

A new Belgian algorithm may help clinicians choose adjuvant therapy more precisely in early endometrial cancer, moving beyond TNM staging alone.

Todays Updates

Belgian Algorithm Reshapes Endometrial Cancer Care

A new Belgian algorithm may help clinicians choose adjuvant therapy more precisely in early endometrial cancer, moving beyond TNM staging alone.

Latest News

Gastrointestinal hypomotility is the most lethal adverse event linked to clozapine use. GLP-1s slow the gut too. Clinicians are combining the two, with little safety data to guide them.

We also report on a flavoring chemical in e-cigarettes that damages human embryo cells in lab experiments.

Elobixibat offers faster and greater symptomatic relief than prucalopride among patients with functional constipation unresponsive to first-line treatment.

Guidelines call for strict limits on invasive tests for pancreatic cyst surveillance, and a new study supports the strategy’s safety.

Wait times for potentially curative cancer surgery, which have been climbing steadily for more than a decade, have risen particularly rapidly at high-volume academic centers.

Two foodborne illness outbreaks linked to Taylor Farms have exposed a weakness at the heart of North America's food system: the United States is increasingly relying on...

News All Time

Mexican Jalapenos Tied to Salmonella Outbreak in 27 US States

U.S. health officials are investigating a Salmonella outbreak linked to Mexican jalapeno peppers that has sickened 345 people in 27 states, prompting supplier ⁠Coast Citrus...

US Cyclosporiasis Probe Linked to Lettuce Widens to 15 States

U.S. health authorities have widened their probe into a cyclosporiasis outbreak tied to iceberg lettuce from central Mexico after detecting cases in six additional states,...

Genetic Marker Linked to Severe Outcomes Across IBD Subtypes

HLA-DRB1*01:03 may serve as a genetic marker for severe outcomes across IBD phenotypes and help identify patients at higher risks for surgery and treatment failure.

Does High-Dose Vitamin D3 Supplementation Improve CRC Survival?

A phase 3 trial was conducted to confirm the benefit of high-dose vitamin D3 supplementation in patients with previously untreated metastatic CRC that was seen in a phase 2 trial.

Small Colorectal Lesions Carry Risk for Deep Invasion

Non-pedunculated colorectal lesions smaller than 2 cm may harbor deep submucosal invasion despite their diminutive size, study finds.

IV Vitamin C With Chemo Shows Signals in Cancer Care

A phase 2 study reported a longer median overall survival in patients receiving IV ascorbate with chemotherapy, although larger randomized trials are needed to confirm the finding.

Etrasimod Effective As First-Line Advanced UC Therapy

Etrasimod can be an effective and safe first-line advanced therapy option in patients with ulcerative colitis who escalate after conventional treatment failure.

Does Doublet Chemotherapy Improve Survival in Rectal Cancer?

Patients with high-risk locally advanced rectal cancer were randomly assigned to receive doublet-LC TNT or conventional neoadjuvant chemoradiotherapy.

Radiation Boost Linked to Better Survival in Rectal Cancer

A phase 2 trial finds that adding a modest radiation boost improves 9-year survival without increasing toxicity, despite no improvement in pathologic complete response.

Creatinine Assay Bias Affects MELD Scoring

Bilirubin interference in commonly used creatinine assays artificially inflates MELD scores in liver transplant candidates, a study reports.

EHR Marker May Help Curb Risk for Liver Transplant Rejection

A remote intervention aimed at improving medication adherence may reduce organ rejection in liver transplant recipients at high risk.

Altimmune Drug Cuts Heavy Drinking in Mid-stage Trial for Alcohol Use Disorder

Altimmune said on Tuesday its experimental drug helped patients with alcohol use disorder cut back on heavy drinking ⁠in a mid-stage trial, sending the company's shares 10%...

Newer Antibiotics Show No Clear Benefit for Staph Infections

A new meta-analysis finds ceftaroline and ceftobiprole monotherapy show no clear advantage over standard therapy for non-urinary Staphylococcus aureus infections.

FDA Approves Freenome's Blood Test for Colorectal Cancer Screening

The U.S. FDA has approved Freenome's blood-based colorectal cancer screening test for older adults, paving the way ⁠for partner Abbott to launch it in the U.S. this fall,...

Company At Center Of US Cyclospora Outbreak Complained to White House, Source Says

U.S. produce supplier Taylor Farms complained to White House and Food and Drug Administration officials about the government's inspection process earlier this month, a...

Poultry Firm Recalls Nearly 1.6 Million Dozen Eggs Over Salmonella Risk, FDA Says

The U.S. FDA said on Wednesday that Midwest Poultry Services is recalling nearly 1.6 ⁠million dozen eggs produced in Texas due to potential Salmonella...

Recommended News For You

Decrease seen in in situ breast cancer since 2009

Can Fasting Around Chemo Improve Ovarian Cancer Outcomes?

Ultrasound imaging of breast cancer tumors offers noninvasive monitoring of treatment effectiveness

Cognitive Bias Modification App Fosters Alcohol Avoidance

Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists

For fit patients with CLL, frontline venetoclax-ibrutinib improves survival.

Dr. Prerana S. Nesargi's message for Childhood Cancer Awareness Month 2023 is to increase understanding of pediatric oncology.

Recommended Articles For You

Advanced Methods in Oncology in Daily Practice 

Exploring The Causes and Consequences of Low Transferrin Saturation 

Clinical Analysis of Prostate Cancer 

Unlocking the Mysteries of Rhabdomyoma: A New Hope for Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Prostate cancer Q&A: Improving detection and reducing overtreatment

2.

FDA Approves Prostate Cancer Combo That Warranted Advisory Meeting

3.

A retrospective study examined the role of CA 19-9 and CEA in duodenal adenocarcinoma prognosis.

4.

Polatuzumab Vedotin Boosts Survival in Relapsed DLBCL

5.

New imaging technique identifies glioblastoma patients who would benefit from immunotherapy

1.

Understanding Villous Adenoma: Causes, Symptoms, and Treatments

2.

Unlocking the Potential of Leukemia Treatment: A New Hope for Patients

3.

Generative AI for Adaptive Oncology Trial Design

4.

The Future is Now: Navigating the Precision Revolution in Oncology Treatment

5.

Esophageal Cancer Survival Rates and Outcomes: Evidence-Based Insights from Oncology Studies

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

1.

From Guidelines to Practice: Hematology

2.

The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift

3.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II

4.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI

5.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot